PHARMACEUTICAL DEVELOPMENT business Vernalis has appointed chartered accountant Nigel Sheail as a non-executive director.
Sheail learned his trade at Ernst & Young, before joining Glaxo.
He has spent much of his career at Hoffman-La Roche, where he has worked in a number of corporate finance and licensing roles in China, the US and Switzerland.
“His depth of experience in the global pharmaceutical industry will be very valuable for the Board, and we look forward to his contribution, as we seek to build future value for Vernalis shareholders,” said Vernalis chairman Peter Fellner.
For more companies and markets data visit the Share Price Centre
Cowgill Holloway and Warings Business Advisors have merged, with a range of growth plans in the North West put in place
Does Darwin's theory apply to taxation? Colin ponders...
The EC has been instructed to draft a European Union (EU) directive authorising an EU financial transaction tax, which would apply to ten of the EU’s 28 member states
Accountancy Age Jobs is delighted to announce the launch of a brand new look website for finance and accountancy professionals